Patents by Inventor Kevin M. Gorman

Kevin M. Gorman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oligonucleotide primers for efficient detection of hepatitis C virus (HCV) and methods of use thereof
    Patent number: 6638714
    Abstract: Described herein are methods and kits for the detection of hepatitis C virus RNA is biological samples obtained from human subjects. The invention includes novel amplification primers and probes useful in the amplification of DNA derived from hepatitis C virus RNA, and kits and methods which incorporate the novel primers.
    Type: Grant
    Filed: January 28, 2000
    Date of Patent: October 28, 2003
    Assignee: Ortho-Clinical Diagnostics, Inc.
    Inventors: Jeffrey M. Linnen, Kevin M. Gorman
  • Oligonucleotide primers for efficient multiplex detection of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) and methods of use thereof
    Patent number: 6623919
    Abstract: Disclosed herein are methods and kits for the simultaneous detection of hepatitis C virus and human immunodeficiency virus in biological samples from human subjects.
    Type: Grant
    Filed: January 28, 2000
    Date of Patent: September 23, 2003
    Assignee: Ortho-Clinical Diagnostics, INC
    Inventors: Kevin M. Gorman, David R. Patterson, Jeffrey M. Linnen, Keming Song
  • Multiplexed PCR assay for detecting disseminated Mycobacterium avium complex infection
    Patent number: 6465638
    Abstract: The present invention relates to nucleic acid primers and probes specific for organisms of the Mycobacterium avium complex (MAC) and to their use in nucleic acid amplification methods for the detection and differentiation of such organisms in biological samples. The invention also relates to diagnostic kits for detecting and differentiating the various organisms comprising the MAC.
    Type: Grant
    Filed: June 23, 1998
    Date of Patent: October 15, 2002
    Assignee: Ortho-Clinical Diagnostics, Inc.
    Inventors: Kevin M. Gorman, John A. McElver, Charles P. Cartwright, David R. Patterson
  • MULTIPLEXED PCR ASSAY FOR DETECTING DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION
    Publication number: 20010019822
    Abstract: The present invention relates to nucleic acid primers and probes specific for organisms of the Mycobacterium avium complex (MAC) and to their use in nucleic acid amplification methods for the detection and differentiation of such organisms in biological samples. The invention also relates to diagnostic kits for detecting and differentiating the various organisms comprising the MAC.
    Type: Application
    Filed: June 23, 1998
    Publication date: September 6, 2001
    Inventors: KEVIN M. GORMAN, JOHN A. MCELVER, CHARLES P. CARTWRIGHT, DAVID R. PATTERSON
  • Separation-free specific binding assays using anti-inhibitor antibodies
    Patent number: 5565326
    Abstract: Specific binding ligands can be detected with an assay which utilizes an immobilized receptor for the ligand, a reporter enzyme, an inhibitor antibody and an anti-inhibitor antibody. Both antibodies are specific for the reporter enzyme. The inhibitor antibody effectively shuts down the activity of the reporter enzyme when it is complexed thereto. The anti-inhibitor antibody binds to the reporter enzyme, does not affect the enzymatic activity, but prevents the binding of the inhibitor enzyme. This assay provides a direct correlation of the target specific binding ligand to the signal generated without the use of separation or wash steps.
    Type: Grant
    Filed: May 31, 1994
    Date of Patent: October 15, 1996
    Assignee: Johnson & Johnson Clinical Diagnostics, Inc.
    Inventors: John L. Daiss, Kevin M. Gorman, Carolyn R. Hinchman